Results 151 to 160 of about 9,057,173 (269)

Nicotinamide N‐methyltransferase promotes drug resistance in lung cancer, as revealed by nascent proteomic profiling

Molecular Oncology, EarlyView.
AZD9291 has shown promise in targeted cancer therapy but is limited by resistance. In this study, we employed metabolic labeling and LC–MS/MS to profile time‐resolved nascent protein perturbations, allowing dynamic tracking of drug‐responsive proteins. We demonstrated that increased NNMT expression is associated with drug resistance, highlighting NNMT ...
Zhanwu Hou, Zhen Wang, Fei Yang, Xiao Han, Lei Li, Huadong Liu   +5 more
wiley   +1 more source

Membrane-bound model of the ternary complex between factor VIIa/tissue factor and factor X. [PDF]

Blood Adv
Muller MP, Mortenson A, Sedzro JC, Wen PC, Morrissey JH, Tajkhorshid E.   +5 more
europepmc   +1 more source

Associations of coagulation factor X and XI with incident acute coronary syndrome and stroke: A nested case-control study. [PDF]

J Thromb Haemost, 2021
Chen H, Shen M, Niu R, Mu X, Jiang Q, Peng R, Yuan Y, Wang H, Wang Q, Yang H, Guo H, He M, Zhang X, Wu T.   +13 more
europepmc   +1 more source

COHERENT AND INCOHERENT X-RAY SCATTERING FACTOR FOR HELIUM AND TWO-ELECTRON ATOMIC IONS. PART II. Report No. L-968.

, 1969
Ronald T. Brown
openalex   +2 more sources

Microglia limit brain tumor development by restricting tumor cell proliferation and inducing T‐cell immunity

Molecular Oncology, EarlyView.
Microglia (BV2) and IL‐4‐treated BMDMs promote astrocytoma clustering and inhibit tumor growth, not shown in other macrophage cells. In vivo, microglial co‐implantation enhances CD8+ T cell infiltration, elevates Granzyme B, lowers circulating MDSCs, and extends survival only in immune‐competent mice, but not in immune‐deficient mice.
Tzu‐Chieh Sun, Ching‐Fang Yu, Sheng‐Yan Wu, Wei‐Chung Cheng, Chi‐Shiun Chiang, Fang‐Hsin Chen   +5 more
wiley   +1 more source

Navigating the Challenges of Factor X Deficiency: A Case Study. [PDF]

Cureus
Chaudhary GA, Bhavsar HM, Mahashabde ML.
europepmc   +1 more source

Response of factor X deficiency to darutumumab in the treatment of AL amyloidosis: a novel finding. [PDF]

BMJ Case Rep, 2021
Mar E, Taylor K, Mollee P.
europepmc   +1 more source

The heterogeneity of the light chains of Factor X

, 1976
Gregory G. Neal, C V Prowse, M. P. Esnouf   +2 more
openalex   +1 more source

Erratum for "The X-ray Atomic Scattering Factors of Aluminium" by Rantavuori E and Tanninen V-P,Physica Scripta, Vol. 15, 273-275 (1977) [PDF]

, 1978
E. Rantavuori, Tanninen V-P
openalex   +1 more source

Bridging the gap: Multi‐stakeholder perspectives of molecular diagnostics in oncology

Molecular Oncology, EarlyView.
Although molecular diagnostics is transforming cancer care, implementing novel technologies remains challenging. This study identifies unmet needs and technology requirements through a two‐step stakeholder involvement. Liquid biopsies for monitoring applications and predictive biomarker testing emerge as key unmet needs. Technology requirements vary by
Jorine Arnouts, Senada Koljenović, Elise Daems, Karolien De Wael, Marc Peeters, Léon C. van Kempen, Greetje Vanhoutte, Karen Zwaenepoel, Timon Vandamme   +8 more
wiley   +1 more source